Driving reinvestment in R&D for antibiotics and advocating their responsible use
Posted on
by
admin in
NAME |
SURNAME |
ORGANISATION |
WORK STREAM |
Stephen |
Harbarth |
University of Geneva |
Coordination of DRIVE-AB and WP3A leader |
Inge |
Gyssens |
University Medical Centre, Nijmegen |
WP1A leader |
Marlies |
Hulscher |
Radboud University Medical Centre, Nijmegen |
WP1A leader |
Jeroen |
Schouten |
Radboud University Medical Centre, Nijmegen |
Partner in WP1A |
Herman |
Goossens |
University of Antwerp |
Partner in WP1A |
Niels |
Adriaenssens |
University of Antwerp |
Partner in WP1A |
Benedikt |
Huttner |
University of Geneva |
Partner in WP1A |
Céline |
Pulcini |
Nice University Hospital |
Partner in WP1A |
Vera |
Vlahović-Palčevski |
Univerisity Hospital Rijeka, Croatia |
Partner in WP1A |
Nicholas |
Brown |
British Society for Antimicrobial Chemotherapy |
Partner in WP1A and WP3B |
Laura |
Piddock |
British Society for Antimicrobial Chemotherapy |
Partner in WP1A and WP3B |
Tracey |
Guise |
British Society for Antimicrobial Chemotherapy |
Partner in WP1A and WP3B |
Yehuda |
Carmeli |
Tel Aviv Sourasky Medical Center |
WP1B Leader |
Evelina |
Tacconelli |
University of Tüebingen |
Partner in WP1B |
Ramanan |
Laxminarayan |
London School of Tropical Medicine and Hygiene |
WP1C Leader |
Timo |
Goeschl |
Heidelberg University |
Partner in WP1C |
Justus |
Wesseler |
Technical University Munich |
Partner in WP1C |
John-Arne |
Røttingen |
Norwegian Institute of Public Health |
Co-leader of WP2 |
Otto |
Cars |
Uppsala University |
Co-leader of WP2 |
Anna |
Zorzet |
Uppsall |
Partner in WP2 |
Rifat |
Atun |
Imperial College London |
Partner in WP2 |
Francesco |
Ciabuschi |
University of Uppsala |
Partner in WP2 |
Enrico |
Baraldi |
University of Uppsala |
Partner in WP2 |
Steve |
McKeever |
University of Uppsala |
Partner in WP2 |
Elias |
Mossialos |
London School of Economics |
Partner in WP2 |
Chantal |
Morel |
London School of Economics and University of Geneva |
Partner in WP2 |
Suzanne |
Edwards |
University of Geneva |
Partner in WP2 |
Christine |
Årdal |
Norwegian Institute of Public Health |
Partner in WP2 |
Steven |
Hoffman |
Norwegian Institute of Public Health |
Partner in WP2 |
Dimitrios |
Gouglas |
Norwegian Institute of Public Health |
Partner in WP2 |
Ursula |
Theuretzbacher |
CEFAIA |
WP3B Leader |
David |
Heymann |
Chatham House |
Partner in WP3B |
Charles |
Clift |
Chatham House |
Partner in WP3B |
Brigitte |
Nolet |
Roche, Head of Global Public Policy |
Co-leader of WP3B |
Ka |
Lumb |
Roche, Head of Global Pricing and Market Access, Immunology, Infectious Diseases and Ophthalmology |
Participant in WP1C and WP2 |